UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000050727
Receipt number R000057794
Scientific Title Exploratory study on effects of Tochu (Eucommia ulmoides) leaf extract components on vascular and inflammatory indices in chronic kidney disease.
Date of disclosure of the study information 2023/03/30
Last modified on 2024/09/29 09:33:21

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Exploratory study on effects of Tochu (Eucommia ulmoides) leaf extract components on vascular and inflammatory indices in chronic kidney disease.

Acronym

Exploratory study on effects of Tochu (Eucommia ulmoides) leaf extract components on vascular and inflammatory indices in chronic kidney disease.

Scientific Title

Exploratory study on effects of Tochu (Eucommia ulmoides) leaf extract components on vascular and inflammatory indices in chronic kidney disease.

Scientific Title:Acronym

Exploratory study on effects of Tochu (Eucommia ulmoides) leaf extract components on vascular and inflammatory indices in chronic kidney disease.

Region

Japan


Condition

Condition

chronic kidney disease

Classification by specialty

Nephrology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To explore effects of oral supplement (product name: Tochu gen Gx) containing Tochu tea extracts, taken at recommended dose for 10 (8-12) weeks, on vascular and inflammatory indices in chronic kidney disease (CKD) patients.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Circulating endothelial progenitor cell numbers by flowcytometry at the start and at the end of Tochu tea supplement administration for 10 (8-12) weeks.

Key secondary outcomes

Circulating monocyte subset ratios (flowcytometry) , serum adiponectin, high-sensetivity CRP, oxidized LDL, oxidative stress (ROM) and anti-oxidative (BAP) indices, at the start and at the end of Tochu tea supplement administration for 10 (8-12) weeks.


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Tochu tea supplement (product name: Tochu gen GX) at recommended dose of 9 tablets per day is administered for 10 (8-12) weeks. Blood samples at the start and at the end of administration are used for outcome measurements including those by flowcytometry.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. Chronic kidney disease patients at stages G1 to G3a (eGFR >45 mL/min/1.73m2) and/or proteinuria of more than 0.15g/gCr (or albuminuria of more than 30mg/gCr).
2. Males and females 20 years or more of age.
3. Those from whom consent to study participation was obtained with use of informed conset document.

Key exclusion criteria

1. Those with malignant disease.
2. Those with dementia or impaired cognitive function.
3. Those with serious comorbid conditions who were judged not suited for participation by physician.

Target sample size

50


Research contact person

Name of lead principal investigator

1st name Hiroshi
Middle name
Last name Satonaka

Organization

Dokkyo Medical University

Division name

Department of Nephrology and Hypertension

Zip code

321-0293

Address

880 Kitakobayashi, Mibu-machi, Shimotsuga-gun, Tochigi-ken, JAPAN

TEL

0282-86-1111

Email

satonakah@nifty.com


Public contact

Name of contact person

1st name Hiroshi
Middle name
Last name Satonaka

Organization

Dokkyo Medical University

Division name

Department of Nephrology and Hypertension

Zip code

321-0293

Address

880 Kitakobayashi, Mibu-machi, Shimotsuga-gun, Tochigi-ken, JAPAN

TEL

0282-86-1111

Homepage URL


Email

satonakah@nifty.com


Sponsor or person

Institute

Dokkyo Medical University

Institute

Department

Personal name



Funding Source

Organization

Japanaese Society of Eucommia

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Clinical Research Review Committee, Dokkyo Medical University Hospital

Address

880 Kitakobayashi, Mibu-machi, Shimotsuga-gun, Tochigi-ken, JAPAN

Tel

+81-282-86-1111

Email

r-kenkyu@dokkyomed.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 03 Month 30 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2021 Year 08 Month 19 Day

Date of IRB

2021 Year 09 Month 21 Day

Anticipated trial start date

2023 Year 03 Month 31 Day

Last follow-up date

2024 Year 08 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2023 Year 03 Month 30 Day

Last modified on

2024 Year 09 Month 29 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000057794